CLINICAL TRIALS IN PROGRESS: LEUKAEMIA AND MULTIPLE MYELOMA.
D000293:Adolescent; D000970:Antineoplastic Agents; D002066:Busulfan; D002648:Child; D003520:Cyclophosphamide; D004358:Drug Therapy; D006801:Humans; D007223:Infant; D007938:Leukemia; D007951:Leukemia, Myeloid; D008558:Melphalan; D015122:Mercaptopurine; D009101:Multiple Myeloma; D009369:Neoplasms / Q000532:radiotherapy*; D010759:Phosphorus Isotopes; D011241:Prednisone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D010759:Phosphorus Isotopes; D003520:Cyclophosphamide; D015122:Mercaptopurine; D002066:Busulfan; D008558:Melphalan; D011241:Prednisone
ADOLESCENCE; ANTINEOPLASTIC AGENTS; BUSULFAN; CHILD; CYCLOPHOSPHAMIDE; DRUG THERAPY; INFANT; LEUKEMIA; LEUKEMIA, MYELOCYTIC; MELPHALAN; MERCAPTOPURINE; MULTIPLE MYELOMA; NEOPLASM RADIOTHERAPY; PHOSPHORUS ISOTOPES; PREDNISONE, THERAPEUTIC